CVRdatabase
Menu

Arcedi Biotech ApS

Private limited companyCVR 25577922VejleActive

Arcedi Biotech ApS is a private limited company, based in Vejle, active in research and experimental development on natural sciences and engineering, founded in 2013. Equity was negative at the end of 2025 (−DKK 173.6m). The company made a loss in both 2024 and 2025, most recently DKK 45.9m. With 26 employees, the company is about 5 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 11.6m+8.1% vs. 2024
Net profit−DKK 45.9m−9.3% vs. 2024
Equity−DKK 173.6m−35.9% vs. 2024
Employees26latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 42m to DKK 45.9m (2024 → 2025).

Employees

  • 1 more employees than a year earlier: 26 (08/2026) against 25 (08/2025).

Management and owners, last 24 months

  • New owners registered: S.h.a.c. ApS (01/11/2024).
  • No longer registered as owner: S.h.a.c.aps (01/11/2024).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 180m−DKK 160m−DKK 140m−DKK 120m−DKK 100m−DKK 80m−DKK 60m−DKK 40m−DKK 20mDKK 0202020212022202320242025
EquityNet profit
Financial figures for Arcedi Biotech ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit4,9033,864−8,906−7,228−12,655−11,636+8.1%
Operating profit (EBIT)−4,549–−29,568−31,892−37,459−38,236−2.1%
Profit before tax−6,316−8,880−33,236−42,216−50,714−50,245+0.9%
Net profit−3,853−5,779−24,201−32,471−41,961−45,882−9.3%
Total assets94,583114,921126,419137,153135,920131,210−3.5%
Equity−23,346−29,125−53,326−85,797−127,758−173,640−35.9%
Liabilities106,214131,606171,186218,402263,678304,850+15.6%
Cash and cash equivalents9452,4861,5371,6491,270540−57.5%
Average number of employees1517242322220%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 173.6m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Arcedi Biotech ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/03/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202431/03/2025The companyPDFXBRL
202301/01/2023 – 31/12/202311/03/2024The companyPDFXBRL
202201/01/2022 – 31/12/202231/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202131/03/2022The companyPDFXBRL
202001/01/2020 – 31/12/202026/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202509/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 11.6mNo. 394 of 421
Better than 6% of the companies in the industry
Equity−DKK 173.6mNo. 427 of 431
Better than 1% of the companies in the industry
Number of employees26No. 87 of 431
Better than 80% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 9,848of 9,892
Better than 0%
No. 9,916of 9,922
Better than 0%
Same industry and 20–49 employees64 companies in the comparison
No. 50of 62
Better than 20%
No. 61of 64
Better than 5%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,514of 33,588
Better than 0%
No. 33,669of 33,687
Better than 0%
All companies of type ApS66,508 companies in the comparison
No. 66,296of 66,379
Better than 0%
No. 66,493of 66,505
Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Arcedi Biotech ApS−DKK 11.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Arcedi Biotech ApS−DKK 45.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Arcedi Biotech ApS−DKK 173.6m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Arcedi Biotech ApS26
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Arcedi Biotech ApS

Management

6 active registrations

Executive management

Executive management at Arcedi Biotech ApS
NameRoleAppointed
John Riis MortensenDirector01/06/2023
Mads Tang DalsgaardCEO01/06/2023

Board of directors

Board of directors at Arcedi Biotech ApS
NameRoleAppointed
Hans-Henrik Horsted EriksenBoard member29/03/2016
Tonni Bülow-NielsenChair of the board28/06/2024
Claus Bagger-SørensenDeputy chair28/06/2024
Søren BirnBoard member28/06/2024
Founders
Zimba Invest ApS
Former management (6)
Former management at Arcedi Biotech ApS
NameRoleAppointedResigned
Hans-Henrik Horsted EriksenDirector16/12/201329/03/2016
John Riis MortensenDirector16/12/201331/05/2023
Steen Bagger-SørensenBoard member29/03/201628/06/2024
Claus Bagger-SørensenChair of the board29/03/201627/06/2024
Palle Schelde JensenCEO29/03/201624/04/2023
Tonni Bülow-NielsenBoard member01/10/202027/06/2024

Signing rule: Selskabet tegnes af formanden i forening med næstformanden eller af en direktør i forening med næstformanden eller af den samlede bestyrelse i forening.

Address and production units

2 active production units

Tabletvej 1
7100 Vejle

Vejle Municipality · Postcode 7100

Other companies at the address (6)

Production units
Production unitAddressEmployeesP number
ARCEDI BIOTECH ApSPalle Juul-Jensens Boulevard 82, 8200 Aarhus N261027643090
ARCEDI BIOTECH ApSTabletvej 1, 7100 Vejle231018974130

Purpose

Selskabets formål er at drive virksomhed med forskning og udviklingsaktiviteter med henblik på kommercialisering samt anden virksomhed, der efter direktionens skøn er forbundet dermed

The purpose is quoted from the register in Danish.

Changes year by year

60 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20249 changesownership 2 · management 6 · accounts 1
  • S.H.A.C. ApS registered as owner (10%)
  • S.H.A.C.ApS is no longer registered as owner
  • Claus Bagger-Sørensen appointed deputy chair
  • Tonni Bülow-Nielsen appointed chair of the board
  • Søren Birn appointed board member
  • Steen Bagger-Sørensen stepped down as board member
  • Tonni Bülow-Nielsen stepped down as board member
  • Claus Bagger-Sørensen stepped down as chair of the board
  • Annual report for 2023 published
202313 changesownership 8 · management 4 · accounts 1
  • BBS Zimba ApS registered as owner (10%)
  • LHBS Zimba ApS registered as owner (10%)
  • EBS Zimba ApS registered as owner (10%)
  • BAKODO ApS registered as owner (15%)
  • BBS Zimba ApS is no longer registered as owner
  • EBS Zimba ApS is no longer registered as owner
  • LHBS Zimba ApS is no longer registered as owner
  • BAKODO ApS is no longer registered as owner
  • John Riis Mortensen appointed director
  • Mads Tang Dalsgaard appointed ceo
  • John Riis Mortensen stepped down as director
  • Annual report for 2022 published
  • Palle Schelde Jensen stepped down as ceo
202212 changesownership 11 · accounts 1
  • BAGGER-SØRENSEN & CO. A/S registered as owner (10%)
  • VECATA INVEST ApS is no longer registered as owner
  • ZIMBA INVEST ApS is no longer registered as owner
  • ZIMBA INVEST ApS registered as owner (20%)
  • BBS Zimba ApS registered as owner (5%)
  • ZIMBA INVEST ApS registered as owner (5%)
  • ZIMBA INVEST ApS is no longer registered as owner
  • EBS Zimba ApS registered as owner (5%)
  • LHBS Zimba ApS registered as owner (5%)
  • Zimba Invest ApS registered as owner (5%)
  • ZIMBA INVEST ApS is no longer registered as owner
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20202 changesmanagement 1 · address 1
  • Tonni Bülow-Nielsen appointed board member
  • Moved to Tabletvej 1, 7100 Vejle
20171 changeaddress 1
  • Moved to Lysholt Allé 10, 2, 7100 Vejle
20165 changesmanagement 5
  • Hans-Henrik Horsted Eriksen appointed board member
  • Steen Bagger-Sørensen appointed board member
  • Claus Bagger-Sørensen appointed chair of the board
  • Palle Schelde Jensen appointed ceo
  • Hans-Henrik Horsted Eriksen stepped down as director
20158 changesownership 8
  • SoLoCa ApS registered as owner (10%)
  • BAKODO ApS registered as owner (15%)
  • S.H.A.C.ApS registered as owner (10%)
  • ZIMBA INVEST ApS registered as owner (20%)
  • VECATA INVEST ApS registered as owner (10%)
  • S.H.A.C.ApS is no longer registered as owner
  • BAKODO ApS is no longer registered as owner
  • ZIMBA INVEST ApS is no longer registered as owner
20143 changesownership 3
  • S.H.A.C.ApS registered as owner (25%)
  • BAKODO ApS registered as owner (25%)
  • ZIMBA INVEST ApS registered as owner (25%)
20133 changesfounded 1 · management 2
  • Registered as ARCEDI BIOTECH ApS
  • Hans-Henrik Horsted Eriksen appointed director
  • John Riis Mortensen appointed director

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction